“…In CBEs, these variants include SECURE-BE3 150 , eA3A-BE3 152 , 166 , hA3G-CBE 167 , AALN-BE4 148 , YE1-BE4 148 , transformer BE (tBE) 168 , AID-2S/AID-3S 169 , and other next-generation CBEs 170 , 171 . In ABEs, SECURE-ABE 135 , ABE7.10-F148A 152 , ABEmaxAW or ABEmaxQW 151 , ABE8e-V106W 136 , ABE-del153 172 and ABE9 (N108Q/L145T) 173 were created to reduce RNA off-targeting and narrow the editing window. Of note, many of these mutations may reduce the deaminase activity.…”